Pyrogen Testing Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2019-2025. Increasing pharmaceutical & biotechnology companies and increasing investments in research & development are key drivers for Global Pyrogen Testing Market.
A pyrogen is a foreign substance that evokes temperature elevation in an animal’s body. Typically, pyrogenic substances include endotoxin and other bacterial by products. Pyrogen detection is mandatory in pharmaceutical, biotechnology or medical devices industries in order to avoid the fever reactions that can be induced by both microbial and non-microbial entities. So, during the study of Global Pyrogen Testing market, we have considered pyrogen testing products and consumables to analyze the market.Global pyrogen testing market report is segmented on the basis of product, test, application and regional & country level. Based on product global pyrogen testing market is classified as instruments, consumables and services. Based upon type, global pyrogen testing market is classified as LAL (Limulus Amebocyte Lysate) tests, In vitro tests and Rabbit tests. Based upon application type, global pyrogen testing market is classified as pharmaceutical & biologics, medical devices, diagnostics and others. The regions covered in this pyrogen testing market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of Pyrogen Testing is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.
Rapidly growing pharmaceutical, biotechnology and medical devices industry, increasing Research & Development investments, favorable government policies, increasing number of new biologics products are driving the growth of the world pyrogen testing market. However, increasing application for animal-free tests and availability of other molecular diagnostics methods are major restrains of the Global Medical Robotic Market. Nonetheless, untapped market and technological advancements may generate new opportunities in forecast period.
North America dominates the pyrogen testing market with highest market share due to presence of many large biotechnology and biopharmaceutical companies such as Pfizer Inc., Merck Group, Celgene Corp., F. Hoffmann-La Roche AG and Amgen Inc. Moreover, highly developed healthcare & research infrastructure and large focus on new drug development are the major factors responsible for continuous growth of this market.
Europe is the second largest market for Pyrogen Testing due to high investments in research and development activities, favorable government policies, establishment of new biotechnology, biopharmaceutical and medical devices companies are the major factors for the growth of the pyrogen testing market in this region. In 2016 research-based pharmaceutical industries invested an estimated approximately USD 40,900 million in Research & Development in Europe.Asia Pacific pyrogen testing market is witnessed with strong growth rate majorly due advancements in drug discovery, development, and production, increasing research & development activities and growing pharmaceutical and biotechnology industries. Clinical research organizations are focusing on Asian countries for clinical trials. In February 2017, a National Reimbursement Drug List (NRDL) update added around 340 new drugs in the list. Among the local biotech companies based in China, there are approximately 800 innovative molecules in the pipeline, among which 70–80 are in phase III.
• Rest of Europe
• South Korea
• Rest Of APAC
• Rest of South America
Middle East and Africa
• Saudi Arabia
• South Africa
• Rest Of MEA